投稿信息
稿件收录要求
Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. This journal has an international authorship and a broad scope in basic, translational and clinical research including but not limited to:
- Epigenetics, genomics and proteomics
- Gene editing
- RNA biology
- Signal transduction
- Structural biology
- Early diagnosis and biomarkers of disease
- Gene therapy, cell therapy and immunotherapy
- Targeted therapy by small molecules
- Molecular imaging
- Artificial intelligence in medicine
- Regenerative medicine
Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. The journal editorial office (molbiomed@med-cens.org and editorial@molbiomed.org) is dedicated to providing professional and responsive service for authors.
The journal covers topics including but not limited to genetics/epigenetics, molecular biology, cell biology, bioinformatics, pharmacology, pharmacy, and clinical medicine. Molecular Biomedicine publishes a range of content types, including original research article, review, letter to the editor and research highlight, offering the latest advances in basic, translational and clinical research to meet the needs of academic readers in this field.
- Covers all aspects of biomedicine: basic, translational and clinical research;
- Prompt and professional editorial processing
- Globally renowned Editorial Board members
- Free of APC for Open Access publishing (2020-2022)
Editor-in-Chief
- Arnold Driessen,
- Yu-quan Wei
